AI Risks · Fierce Biotech

Precise Dx's digital pathology AI on par with genomic testing in predicting breast cancer ...

Fierce Biotech The company—born out of digital pathology work at Mount Sinai Health System—said it aims to categorize patients at either high or lowriskfor …

Read the original at Fierce Biotech ↗

Topics
Healthcare
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”